Grants and Contributions:
Title:
Evaluation of LUCID’s Music-Based Neuromodulation Platform for Personnel Resilience & High-Stress Performance
Agreement Number:
1040026
Agreement Value:
$75,000.00
Agreement Date:
Mar 15, 2026 - Oct 5, 2026
Description:
This project will evaluate the potential of LUCID's AI-enabled digital platform to support personnel resilience and high-stress performance.
Organization:
National Research Council Canada
Expected Results:
The expected results and outcomes of NRC Industrial Research Assistance Program is focused on growing small and medium-sized enterprises (SMEs) through innovation and wealth creation for Canada.
Location:
Toronto, Ontario, CA M4T 1P7
Reference Number:
172-2025-2026-Q4-1040026
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Business Number:
784783318
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 75,000 dollars.
Amendment Date
Mar 17, 2026
Recipient's Operating Name:
Lucid Therapeutics
Recipient's Legal Name:
Lucid, inc.
Federal Riding Name:
University--Rosedale
Federal Riding Number:
35110
Program:
Industrial Research Assistance Program
Program Purpose:
The purpose of Industrial Research Assistance Program Contributions to Firms is to provide support that assists small and medium-sized enterprises (SMEs) to advance their innovation knowledge and ability to innovate, grow through innovation and stimulate wealth creation for Canada.
Coverage:
Industrial Research Assistance Program projects stimulate wealth creation for Canada through technological innovation and strengthen Canadian innovation ecosystem by creating new industrial capacity.
NAICS Code:
51121
Amendments: